Skip to main content
. 2018 Aug 7;8(16):4477–4490. doi: 10.7150/thno.26249

Figure 6.

Figure 6

CRP and metabolites vs. the clinical degree of change. The proteins MBP and MDC and the metabolites 20β-DHF and 5,6-DH-PGF1 showed statistically significant differences between the groups, where 1 corresponds to no clinical change, 2 to an intermediate clinical change and 3 to a severe clinical change. The levels for the transitioning patients have been marked on the y-axis in blue arrows.